Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › LA › LEESVILLE › CLHG-LEESVILLE

CLHG-LEESVILLE

NPI: 1881665164 · LEESVILLE, LA 71446 · General Acute Care Hospital · NPI assigned 01/27/2006

$16.30M
Total Medicaid Paid
360,084
Total Claims
310,531
Beneficiaries
209
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialQUINN, KEVIN (CEO)
NPI Enumeration Date01/27/2006

Related Entities

Other providers sharing the same authorized official: QUINN, KEVIN

ProviderCityStateTotal Paid
CLHG-LEESVILLE LLC LEESVILLE LA $32K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 29,929 $1.17M
2019 29,248 $924K
2020 25,791 $873K
2021 51,465 $2.21M
2022 78,255 $3.32M
2023 78,146 $4.05M
2024 67,250 $3.75M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99284 Emergency department visit for the evaluation and management, high severity 20,480 18,523 $3.76M
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 9,659 8,552 $2.48M
99283 Emergency department visit for the evaluation and management, moderate severity 20,004 18,360 $2.26M
74176 Computed tomography, abdomen and pelvis; without contrast material 1,643 1,458 $1.25M
74177 Computed tomography, abdomen and pelvis; with contrast material 743 678 $701K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 11,238 9,462 $675K
70450 Computed tomography, head or brain; without contrast material 1,675 1,473 $532K
71045 Radiologic examination, chest; single view 9,674 8,515 $405K
58662 791 514 $394K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 2,220 1,856 $247K
87428 8,345 7,533 $246K
G0378 Hospital observation service, per hour 915 713 $246K
80053 Comprehensive metabolic panel 30,164 25,359 $217K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 33,994 28,541 $180K
80050 General health panel 4,049 3,753 $164K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 421 391 $150K
88305 Level IV - Surgical pathology, gross and microscopic examination 2,461 2,130 $134K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 6,238 4,759 $100K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 332 295 $82K
93017 289 263 $81K
80061 Lipid panel 6,538 6,051 $77K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 719 623 $74K
94060 269 257 $69K
59025 Fetal non-stress test 505 206 $64K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 998 905 $59K
84484 7,637 5,981 $55K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 998 902 $50K
83880 2,347 2,015 $49K
99282 Emergency department visit for the evaluation and management, low to moderate severity 738 683 $49K
71046 Radiologic examination, chest; 2 views 1,073 1,001 $48K
88312 1,390 1,264 $46K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 1,373 1,215 $42K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 3,000 2,741 $42K
81001 18,644 16,342 $42K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 1,276 1,152 $39K
83036 Hemoglobin; glycosylated (A1C) 4,527 4,184 $39K
96361 Intravenous infusion, hydration; each additional hour 923 749 $38K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 652 552 $38K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 1,525 1,379 $37K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material 64 61 $36K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 1,199 1,089 $36K
96375 Therapeutic injection; each additional sequential IV push 1,024 870 $36K
81025 4,867 4,406 $34K
J1885 Injection, ketorolac tromethamine, per 15 mg 9,013 8,080 $30K
36415 Collection of venous blood by venipuncture 16,498 13,664 $29K
88142 1,630 1,509 $29K
84439 3,710 3,379 $29K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 142 132 $26K
82553 4,388 3,465 $26K
94729 300 281 $24K
94726 291 273 $23K
85730 6,038 5,288 $23K
87086 Culture, bacterial; quantitative colony count, urine 3,511 3,087 $21K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 835 766 $21K
82550 5,293 4,246 $20K
83735 4,489 3,619 $20K
83690 3,838 3,430 $20K
93880 117 109 $19K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 525 496 $19K
73562 205 190 $19K
83721 2,584 2,126 $18K
93970 77 68 $18K
85610 6,503 5,727 $17K
J0696 Injection, ceftriaxone sodium, per 250 mg 2,663 2,389 $17K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 754 699 $16K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 1,136 1,063 $15K
72110 143 138 $15K
93976 610 536 $15K
84443 Thyroid stimulating hormone (TSH) 987 918 $14K
81514 70 63 $14K
93925 46 40 $12K
88112 469 401 $11K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 365 340 $11K
64721 40 26 $11K
73630 183 153 $10K
73130 205 164 $9K
99281 Emergency department visit for the evaluation and management, self-limited or minor 212 199 $9K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 19 17 $9K
72141 16 15 $9K
94664 270 224 $9K
C1760 Closure device, vascular (implantable/insertable) 90 66 $8K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation 33 28 $8K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring 49 23 $8K
87807 649 582 $7K
29880 13 13 $7K
72125 Computed tomography, cervical spine; without contrast material 13 12 $7K
76830 Ultrasound, transvaginal 73 68 $7K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 397 350 $7K
49322 43 31 $7K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 387 362 $7K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 68 65 $7K
82746 530 479 $7K
87040 999 577 $6K
80074 158 141 $6K
82607 501 452 $6K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 119 108 $5K
80048 Basic metabolic panel (calcium, ionized) 1,374 1,230 $5K
J2360 Injection, orphenadrine citrate, up to 60 mg 520 468 $5K
85576 741 531 $5K
85027 818 768 $5K
94618 86 80 $4K
72050 45 45 $4K
71250 14 12 $4K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited 48 38 $4K
93015 14 13 $4K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 3,153 2,823 $3K
45384 12 12 $3K
87400 271 226 $3K
84703 353 328 $3K
73030 41 36 $3K
72084 14 14 $3K
87088 359 319 $3K
86592 694 631 $3K
84702 255 201 $3K
86140 589 539 $3K
96376 82 38 $3K
J2405 Injection, ondansetron hydrochloride, per 1 mg 5,810 5,111 $2K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) 13 12 $2K
82150 419 376 $2K
73560 41 26 $2K
J0780 Injection, prochlorperazine, up to 10 mg 184 170 $2K
76000 284 257 $2K
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose 19 17 $2K
85379 282 253 $2K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 26 12 $2K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal 13 12 $2K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 69 46 $2K
86850 476 357 $2K
83874 194 115 $2K
87186 274 150 $2K
87077 680 511 $2K
86787 145 131 $2K
83605 261 189 $2K
87529 38 28 $1K
73110 43 28 $1K
85652 609 549 $1K
82728 114 105 $1K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) 71 66 $1K
J0500 Injection, dicyclomine hcl, up to 20 mg 44 39 $1K
J1644 Injection, heparin sodium, per 1000 units 299 104 $1K
86900 530 426 $1K
73564 15 13 $1K
J1200 Injection, diphenhydramine hcl, up to 50 mg 521 477 $1K
84100 384 228 $982.84
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 15 15 $975.00
83550 134 120 $945.77
86901 431 345 $887.95
84481 69 68 $874.19
J2795 Injection, ropivacaine hydrochloride, 1 mg 1,202 1,060 $815.87
94760 55 27 $811.62
87797 31 29 $791.41
G0463 Hospital outpatient clinic visit for assessment and management of a patient 20 19 $788.31
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 31 25 $763.80
J2270 Injection, morphine sulfate, up to 10 mg 1,031 839 $749.93
J7120 Ringers lactate infusion, up to 1000 cc 509 434 $704.92
83540 134 120 $700.15
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 31 25 $687.18
80069 83 78 $659.55
84134 102 93 $619.33
86703 43 39 $560.43
82677 26 25 $551.44
80305 47 46 $511.48
J0690 Injection, cefazolin sodium, 500 mg 2,639 1,966 $503.41
73090 14 12 $479.10
85018 265 248 $417.79
J0153 Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) 31 27 $415.40
J2704 Injection, propofol, 10 mg 7,067 5,640 $388.75
82105 26 25 $382.45
86336 26 25 $355.54
86762 29 25 $346.99
84403 13 13 $283.91
84402 13 13 $280.17
J1170 Injection, hydromorphone, up to 4 mg 529 415 $269.47
84270 13 13 $239.03
87340 28 25 $238.77
88304 755 702 $212.46
85378 43 40 $200.46
84153 12 12 $185.74
C9113 Injection, pantoprazole sodium, per vial 21 15 $183.26
87481 67 57 $182.47
87081 29 26 $179.01
86738 13 13 $161.52
83655 14 13 $158.64
90961 12 12 $156.58
80320 13 12 $156.00
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 100 95 $148.21
82950 33 29 $138.26
J3010 Injection, fentanyl citrate, 0.1 mg 4,314 3,771 $137.67
87070 19 15 $137.41
86039 14 12 $136.16
76937 85 72 $113.11
J2250 Injection, midazolam hydrochloride, per 1 mg 4,848 4,157 $84.11
82948 47 41 $77.58
84550 28 27 $76.84
82043 17 15 $57.80
82947 18 12 $55.41
J2765 Injection, metoclopramide hcl, up to 10 mg 139 119 $52.11
82570 17 15 $51.80
82610 12 12 $50.48
J2550 Injection, promethazine hcl, up to 50 mg 45 39 $39.20
J0171 Injection, adrenalin, epinephrine, 0.1 mg 414 272 $38.78
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 2,093 1,687 $35.68
J1030 Injection, methylprednisolone acetate, 40 mg 322 298 $27.09
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg 411 351 $13.49
J2060 Injection, lorazepam, 2 mg 16 13 $7.05
74420 31 24 $0.00
00000 30 28 $0.00
J2175 Injection, meperidine hydrochloride, per 100 mg 54 50 $0.00
Q0244 Injection, casirivimab and imdevimab, 1200 mg 52 28 $0.00